LSV Asset Management filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position of 5,868,895 shares of GoodRx Holdings, Inc. Class A Common Stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: LSV Asset Management reported beneficial ownership of 5,868,895 shares of GoodRx Holdings Class A Common Stock.
  • Percent of class: The filing states the position represents 5.48% of the class, also listed as 5.5% in the cover schedule.
  • Sole voting power: LSV Asset Management holds sole voting power over 2,982,356 shares, with 0 shares subject to shared voting power.
  • Sole dispositive power: The filing reports sole dispositive power over all 5,868,895 shares, with no shared dispositive power.
  • Client accounts: According to the filing, clients of LSV Asset Management, including funds and/or managed accounts, have the right to receive or direct the receipt of dividends or sale proceeds from these securities.
  • Triggering date: The date of the event requiring the filing is listed as September 30, 2026.

LSV Asset Management Discloses Position in GoodRx Holdings Class A Shares

LSV Asset Management, a Delaware-organized investment adviser, submitted a Schedule 13G disclosing its beneficial ownership in GoodRx Holdings, Inc. (NASDAQ:GDRX) as of September 30, 2026. The filing was signed by Josh O'Donnell, Chief Compliance Officer, and dated November 10, 2026. LSV Asset Management's principal business office is located at 155 North Wacker Drive, Suite 4600, Chicago, Illinois, 60606.

According to the filing, LSV Asset Management beneficially owns 5,868,895 shares of Class A Common Stock, representing 5.48% of the class (CUSIP 38246G108). Of those shares, the firm reports sole voting power over 2,982,356 shares and sole dispositive power over the full 5,868,895 shares. The filing reports zero shared voting power and zero shared dispositive power. The filing identifies LSV Asset Management as an investment adviser, consistent with reporting under Rule 13d-1(b).

The filing states that "the clients of LSV Asset Management, including funds and/or managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, securities of the Issuer." The filing further certifies that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

LSV Asset Management filed a Schedule 13G on November 10, 2026, reporting beneficial ownership of 5,868,895 shares of GoodRx Holdings Class A Common Stock, equal to 5.48% of the class, with the event date of September 30, 2026.